The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis
 
Consulting or Advisory Role - AstraZeneca; Novartis; Roche/Genentech
 
Research Funding - MedImmune; Novartis
Phase I study of ceritinib in pediatric patients (Pts) with malignancies harboring a genetic alteration in ALK (ALK+): Safety, pharmacokinetic (PK), and efficacy results.
 
Birgit Geoerger
Research Funding - Novartis (Inst)
 
Johannes Schulte
No Relationships to Disclose
 
Christian M. Zwaan
Honoraria - Bristol-Myers Squibb; Celgene; Novartis; Sunesis Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Novartis; Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Pfizer
 
Michela Casanova
Consulting or Advisory Role - Novartis
 
Matthias Fischer
Consulting or Advisory Role - Novartis
Research Funding - Boehringer Ingelheim; Novartis
 
Lucas Moreno
No Relationships to Disclose
 
Toby Trahair
No Relationships to Disclose
 
Irene Jimenez
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Hyoung Jin Kang
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis
 
Alberto S. Pappo
Consulting or Advisory Role - ZIOPHARM Oncology
 
Eric Schafer
No Relationships to Disclose
 
Brian D. Weiss
No Relationships to Disclose
 
Mary Ellen Healy
Employment - Novartis
 
Ke Li
Employment - Novartis
 
Tiffany Lin
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Anthony Boral
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Andrew DJ Pearson
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis